Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Michelson takes $1.2m for OCT system

This article was originally published in Clinica

Executive Summary

UK medical imaging start-up Michelson Diagnostics is set to complete development of its hand-held optical coherence technology (OCT) system for diagnosing and treating cancer, after having raised £600,000 ($1.2m) in additional funding. Some £250,000 came from Catapult Venture Managers, £50,000 from London See Capital and the rest from private investors. London-based Michelson said its OCT system allows for an "optical biopsy" by providing real-time images of sub-surface tissue without having to remove the tissue.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041658

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel